Vanguard Portfolio Management’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.69M Sell
65,015
-10,797
-14% -$266K ﹤0.01% 2758
2026
Q2
$1.69M Buy
75,812
+72,132
+1,960% +$1.56M ﹤0.01% 2798
2026
Q1
$95.3K Buy
+3,680
New +$99K ﹤0.01% 3078

Other funds holding SGP

Vanguard Portfolio Management's SGP Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its SpyGlass Pharma (SGP) stake by 14% in Q3 2026, selling an estimated $266K and leaving 65,015 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Vanguard Portfolio Management first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Vanguard Portfolio Management held 65,015 shares of SpyGlass Pharma worth $1.69M as of Q3 2026.
  • Vanguard Portfolio Management sold 10,797 SpyGlass Pharma shares in Q3 2026, an estimated $266K.
  • SpyGlass Pharma made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2758 holding.
  • Vanguard Portfolio Management first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
  • 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.